Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy.: A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures.: A single-center prospective controlled trial

被引:135
|
作者
Ozcan, Einin E. [1 ]
Guneri, Seina [1 ]
Akdeniz, Bahri [1 ]
Akyildiz, Ilke Z. [1 ]
Senaslan, Omer [1 ]
Baris, Nezihi [1 ]
Aslan, Ozgur [1 ]
Badak, Ozer [1 ]
机构
[1] Dokuz Eylul Univ, Sch Med, Dept Cardiol, TR-35340 Izmir, Turkey
关键词
D O I
10.1016/j.ahj.2007.05.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Several protective therapies have been developed to prevent contrast-induced nephropathy (CIN). We aimed to investigate the efficacy of sodium bicarbonate by comparing 2 other regimens, including combination of N-acetylcysteine (NAC) plus sodium chloride and sodium chloride alone, to prevent CIN in patients undergoing cardiovascular procedures. Methods We prospectively enrolled 264 patients who were scheduled for cardiovascular procedures and had a baseline creatinine level > 1.2 mg/dL. The patients were assigned I of, 3 prophylactic regimens: infusion of sodium bicarbonate, sodium chloride, sodium chloride plus oral NAC (600 mg bid). Contrast-induced nephropathy was defined as an increase in serum creatinine level 25% or 0.5 mg/dL after 48 hours. Results There were no significant differences among groups regarding baseline demographic properties and nephropathy risk factors. The change in creatinine clearance was significantly better in the sodium bicarbonate group than other 2 groups (P = .007). The incidence of CIN was significantly lower in the sodium bicarbonate group (4.5%) compared with sodium chloride alone (13.6%, P = .036) and tended to be lower than in the combination group (12.5%, P = .059). After adjusting the Mehran nephropathy risk score, the risk of CIN significantly reduced with sodium bicarbonate compared with sodium chloride alone (adjusted risk ratio 0.29, P = .043). Conclusions Hydration with sodium bicarbonate provides better protection against CIN than the sodium chloride infusion does alone. Combination therapy of NAC plus sodium chloride did not offer additional benefit over hydration with sodium chloride alone.
引用
收藏
页码:539 / 544
页数:6
相关论文
共 50 条
  • [21] Sodium Bicarbonate in Saline Infusion Is Worse for the Prevention of Contrast-Induced Nephropathy than Saline Infusion Alone: A Randomized Single-Center Study
    Zemanek, David
    Celeryn, Simon
    Hajek, Petr
    Maly, Martin
    Veselka, Josef
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 16B - 17B
  • [22] N-Acetylcysteine and/or Ascorbic Acid versus Placebo to Prevent Contrast-Induced Nephropathy in Patients Undergoing Elective Cardiac Catheterization: The NAPCIN Trial; A Single-Center, Prospective, Randomized Trial
    Habib, Mohammed
    Hillis, Alaa
    Hammad, Amen
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2016, 27 (01) : 55 - 61
  • [23] Prevention of contrast-induced nephropathy in patients after percutaneous coronary intervention: A single-center prospective study
    Glaza, Michal
    Rutkowski, Boleslaw
    Szolkiewicz, Marek
    CLINICAL NEPHROLOGY, 2018, 90 (05) : 370 - 372
  • [24] A New Protocol Using Sodium Bicarbonate for the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography
    Motohiro, Masayuki
    Kamihata, Hiroshi
    Tsujimoto, Satoshi
    Seno, Takeshi
    Manabe, Kenichi
    Isono, Tsuyoshi
    Sutani, Yasuo
    Yuasa, Fumio
    Iwasaka, Toshiji
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (11): : 1604 - 1608
  • [25] A prospective randomized trial comparing normal saline and sodium bicarbonate with or without N-acetyleysteine for prevention of contrast-induced nephropathy
    Shaikh, Forced
    Maddikunta, Rojesh
    Museitif, Raaid
    Haddadian, Babak
    Dochee, Jennifer
    Qureshi, Jamal
    Wallach, Jeffrey D.
    Solis, Joaquin
    Tumuluri, Ramagopal
    Bajwa, Tanvir
    Allaqaband, Suhail
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 122L - 123L
  • [26] Sodium Bicarbonate versus Sodium Chloride and Oral N-Acetylcysteine for the Prevention of Contrast-Induced Nephropathy in Advanced Chronic Kidney Disease
    Shavit, Linda
    Korenfeld, Roman
    Lifschitz, Meyer
    Butnaru, Ady
    Slotki, Itzchak
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2009, 22 (06) : 556 - 563
  • [27] Use of intravenous dose of N-acetylcysteine for the prevention of contrast-induced nephropathy in high risk coronary patients. A randomised controlled trial
    Carbonell, N.
    Blasco, M. L.
    Manez, R. Sanjuan
    Sanchis, J.
    Bodi, V.
    Insa, L.
    EUROPEAN HEART JOURNAL, 2005, 26 : 425 - 425
  • [28] Prevention of Contrast-Induced Nephropathy by Bolus Injection of Sodium Bicarbonate in Patients With Chronic Kidney Disease Undergoing Emergent Coronary Procedures
    Ueda, Hiromichi
    Yamada, Takahisa
    Masuda, Masaharu
    Okuyama, Yuji
    Morita, Takashi
    Furukawa, Yoshio
    Koji, Tanaka
    Iwasaki, Yusuke
    Okada, Takeshi
    Kawasaki, Masato
    Kuramoto, Yuki
    Naito, Takashi
    Fujimoto, Tadao
    Komuro, Issei
    Fukunami, Masatake
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (08): : 1163 - 1167
  • [29] PREVENTION OF CONTRAST-INDUCED NEPHROPATHY WITH BOLUS INJECTION OF SODIUM BICARBONATE IN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING AN EMERGENT CORONARY PROCEDURE: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL
    Ueda, Hiromichi
    Yamada, Takahisa
    Okuyama, Yuji
    Morita, Takashi
    Furukawa, Yoshio
    Tanaka, Koji
    Iwasaki, Yusuke
    Yasui, Taku
    Okada, Takeshi
    Kawasaki, Masato
    Kuramoto, Yuki
    Fukunami, Masatake
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [30] LOW DOSE OF N-ACETYLCYSTEINE PLUS ASCORBIC ACID VERSUS HYDRATION WITH (SALINE 0.9%) FOR PREVENTION OF CONTRAST-INDUCED NEPHROPATHY IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
    Habib, M.
    Hillis, A.
    Hamad, A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 163 : S81 - S81